Bench to bedside: Multiple facets of cannabinoid control in epilepsy

Area of Science:

• Neuroscience
• Pharmacology

Background:

• Epilepsy is a neurological disorder characterized by excessive neuronal excitability.
• The endocannabinoid system, a key regulator of synaptic inhibition, is implicated in epilepsy.
• Cannabinoid receptors are found on presynaptic terminals, with varied distribution across brain regions and synapses.

Purpose of the Study:

• To review recent advances in understanding cannabinoid control of seizures.
• To discuss current confusion and provide research directions for cannabinoid-based epilepsy therapies.

Main Methods:

• Review of preclinical and clinical studies on the endocannabinoid system and epilepsy.
• Analysis of cell-type specific and spatiotemporal regulation of cannabinoid receptors and endocannabinoids in seizures.
• Examination of cannabidiol's clinical efficacy and proposed mechanisms.

Main Results:

• Evidence suggests altered cannabinoid receptor expression and endocannabinoid levels during seizures.
• Interventions targeting cannabinoid receptors or endocannabinoids can modulate seizure activity.
• Cannabidiol shows promise in reducing seizures in treatment-resistant epilepsy, though mechanisms are not fully elucidated and may be independent of the endocannabinoid system.

Conclusions:

• The endocannabinoid system plays a significant role in epilepsy, with potential therapeutic targets.
• Further research is needed to clarify the precise mechanisms of cannabinoid action in epilepsy.
• Cannabinoid-based therapies offer promising avenues for precise, individualized epilepsy treatment.